Immune and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Food Allergy
- Peanut Allergy
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 200-250 children undergoing DBPCFC to peanut to identify 98 with high threshold peanut allergy for randomization in trial.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 4 years and 14 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03907397
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
- Investigators
- Principal Investigator: Scott Sicherer, MD Icahn School of Medicine at Mount Sinai